Here is a comprehensive overview of Ankylosing Spondylitis from the medical textbooks:
Ankylosing Spondylitis (AS)
Definition
Ankylosing spondylitis (AS) - now also called radiographic axial spondyloarthritis - is a chronic, multisystem inflammatory spondyloarthropathy primarily affecting the axial skeleton (spine and sacroiliac joints). Sacroiliitis and enthesitis of the axial skeleton are the hallmarks. - Goldman-Cecil Medicine; Grainger & Allison's Diagnostic Radiology
Epidemiology
- Prevalence: ~0.2% of the general population
- ~2% of HLA-B27 positive individuals develop AS
- ~20% of HLA-B27 positive individuals with an affected family member develop AS
- Male : Female = 3 : 1 (historically up to 5:1, but more recent studies show lower ratio)
- Onset: typically young adults, can begin in adolescence
Pathogenesis (Pathobiology)
- Strongly associated with HLA-B27 (90% of patients)
- HLA-B27 has a unique tendency to misfold in the endoplasmic reticulum, triggering a pro-inflammatory cascade called the unfolded protein response
- HLA-B27 also forms heavy-chain homodimers on the cell surface, contributing to inflammation
- Molecular mimicry with gram-negative enteric bacteria has been proposed
- Gut microbiome plays a role - germ-free HLA-B27 transgenic rats show markedly reduced joint disease
- Inflammation begins at entheses (sites where ligaments/tendons insert into bone), especially around the sacroiliac joints and spine
Clinical Features
Axial Symptoms (Primary)
- Chronic low back pain lasting > 3 months
- Inflammatory pattern: worse in the morning, improves with exercise, NOT relieved by rest
- Early-morning stiffness (often lasting hours)
- Pain around sacroiliac joints, may radiate to buttocks
- Back pain that wakes the patient from sleep is a red flag for inflammatory back pain
- Fatigue is common
As Disease Progresses
- Progressive loss of spinal mobility
- Reduced chest expansion (< 2.5 cm is specific for AS)
- Forward stoop / kyphosis
Peripheral Joint Involvement (~30%)
- Asymmetric oligoarthritis, predominantly lower limbs
- Hip joints - second most commonly affected (after sacroiliac joints)
- Enthesitis: Achilles tendinitis, plantar fasciitis (heel pain)
Extra-articular Manifestations
| System | Manifestation |
|---|
| Eyes | Acute anterior uveitis (iritis) - up to 40% of patients |
| Lungs | Upper lobe fibrosis/bullous disease (pulmonary manifestation) |
| Heart | Aortitis, aortic regurgitation, conduction defects |
| Gut | Association with IBD (Crohn's/UC) |
MRI of Sacroiliac Joints in AS
T1-weighted image (A) shows erosions in the sacroiliac joints with joint space loss. T2 fat-suppressed image (B) shows extensive subchondral oedema reflecting active disease.
MRI of Thoracic Spine in AS
STIR sagittal MRI of the thoracic spine showing oedema within the costovertebral joints at multiple levels, characteristic of AS.
Radiology
| Stage | Finding |
|---|
| Early | Subchondral bone marrow oedema on MRI (sacroiliac joints) |
| Early X-ray | Romanus lesions - sclerotic "shiny corners" of vertebral bodies |
| Intermediate | Squared vertebral bodies, thin marginal syndesmophytes |
| Late/Severe | Bamboo spine - complete fusion of vertebral bodies and sacroiliac joints |
Note: Spinal fractures are a serious complication - the fused, osteopenic spine is paradoxically brittle and transverse fractures can be catastrophic.
Diagnostic Criteria
Modified New York Criteria for AS
Clinical criteria:
- Low back pain and stiffness for > 3 months, improves with exercise but not rest
- Limitation of lumbar spine motion in both sagittal and frontal planes
- Limitation of chest expansion
Radiologic criterion:
- Sacroiliitis: grade ≥2 bilateral, or grade 3-4 unilateral
Definite AS = Radiologic criterion + at least 1 clinical criterion
Probable AS = All 3 clinical criteria present, OR radiologic criterion without clinical criteria
Differential Diagnosis
| Feature | Rheumatoid Arthritis | AS | Psoriatic Arthritis | Reactive Arthritis |
|---|
| M:F ratio | 1:3 | 3:1 | 1:1 | 10:1 |
| HLA | DR4 | B27 | B27 (axial) | B27 |
| Joint pattern | Symmetric peripheral | Axial | Axial + asymmetric peripheral | Axial + asymmetric peripheral |
| Sacroiliac | Absent | Bilateral, symmetric | Asymmetric | Asymmetric |
| Syndesmophytes | Absent | Smooth, marginal | Coarse, nonmarginal | Coarse, nonmarginal |
| Eye | Scleritis | Iritis | +/- | Iritis + conjunctivitis |
| RF | >80% | Rare | Rare | Rare |
Treatment
Step 1 - NSAIDs: Continuous NSAIDs are preferred over on-demand use for axial disease.
Step 2 - Biologics (if inadequate NSAID response):
- Anti-TNF agents (e.g., infliximab, adalimumab, etanercept) - first-line biologic
- IL-17 inhibitors (e.g., secukinumab, ixekizumab) - strongly recommended for active AS with inadequate NSAID response; preferred over TNF inhibitors in patients with demyelinating disease risk
Note: Sulfasalazine and methotrexate (DMARDs) are only recommended for peripheral arthritis, not axial disease.
Physical therapy and exercise are important throughout all stages. - Goldman-Cecil Medicine; Rheumatology 2-Volume Set (Elsevier 2022)